Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.990
-0.210 (-4.04%)
At close: Dec 5, 2025, 4:00 PM EST
5.10
+0.11 (2.20%)
After-hours: Dec 5, 2025, 7:56 PM EST
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $638.05 million as of December 5, 2025. Its market cap has decreased by -19.19% in one year.
Market Cap
638.05M
Enterprise Value
401.14M
1-Year Change
-19.19%
Ranking
Category
Stock Price
$4.99
Market Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $638.05M, a decrease of -71.78%. That is a compound annual growth rate of -25.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 638.05M | -23.68% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |